Tissue sections showed that LF-CQPC07 alleviates the hypertrophy of adipocytes, and it also significantly reduced the levels of the inflammatory factors TNF-α, IL-6, IL-1β, and IFN-γ, and increased the levels of anti-inflammatory factors IL-10, IL-4, thereby inhibiting chronic low-grade inflammation associated with obesity. Here, IL4 is linked to obesity disorder.